期刊文献+

构建的Flt3L胞外域原核表达载体在大肠杆菌中的表达 被引量:1

Construction of prokaryotic expression plasmid for Flt3 ligand extracellular domain and its expression in Escherichia coli
下载PDF
导出
摘要 目的:构建含组氨酸标签的FMS样酪氨酸激酶3配体(Fms-like tyrosine kinase 3 ligand,Flt3L)胞外域蛋白的原核表达载体,并在大肠杆菌中进行表达。方法:依据Flt3L基因序列设计引物,以RT-PCR的方法从小鼠脾脏总RNA中克隆Flt3L基因并构建其胞外域原核表达载体,测序鉴定后在大肠杆菌BL21(DE3)菌株中诱导表达,用免疫印迹鉴定。结果:克隆到Flt3L编码区全长序列,经DNA测序证明与已报道的序列相同;构建羧基端带有His6标签的Flt3L胞外域蛋白的原核表达载体,转化大肠杆菌后SDS-PAGE分析显示在BL21(ED3)中获得较高表达;免疫印迹分析表明IPTG诱导后表达的Flt3L胞外域蛋白的相对分子质量(Mr)为19 000,与理论值相符,此蛋白与抗His6标签的抗体发生特异性反应。结论:成功克隆Flt3L基因,构建其胞外域蛋白的原核表达载体,并在大肠杆菌中获得表达。 Aim: To clone the eDNA of FMS-like tyrosine kinase 3 ligand (Flt3L) and to construct the prokaryotic expression vector for the Flt3 ligand extracellular domain fused with a His6 tag and express in Escherichia coli (E. coli). Methods: The primers were designed according to the Flt3L gene, and the eDNA for Flt3L was cloned by RT-PCR from the mouse spleen total RNA and confirmed by DNA sequencing. The DNA fragment encoding Flt3L extracellular domain was amplified by PCR with the sequenceverified Flt3L eDNA as a template and then cloned into pET-3c vector. After confirmed by DNA sequencing once again, the prokaryotic expression vector was transformed into BL21 (DE3) strain. The recombinant protein was expressed in E. coli after IPTG induction. SDS-PAGE and Western blot analyses were employed to detect the expressed fusion protein. Results: DNA sequence analysis showed that the eDNA encoding Flt3L was cloned. The expression vector for the recombinant Flt3L extracellular domain was then constructed and verified by DNA sequencing. SDS-PAGE analysis revealed that the fusion protein was highly expressed in E. coli. Furthermore, Western blotting showed that the recombinant protein existed largely in the inclusion bodies. The fusion protein had a molecular weight of about 19 000, which is in accordance with the theoretical value. Conclusion: The cDNA of Flt3L was cloned and the prokaryotic expression vector for the fusion protein of Flt3L was constructed. The recombinant protein was highly expressed as the form of inclusion bodies in E. coli, which would facilitate the further study of soluble Flt3L.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2008年第4期331-335,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金项目(30572199 30230350和30371651) 生物化学与分子生物学广东省重点学科资助项目
关键词 FMS样酪氨酸激酶3配体 胞外域 原核表达 组氨酸标签 FMS-like tyroslne kinase 3 ligand extracellular domain prokaryotic expression hexahistidine tag
  • 相关文献

参考文献14

  • 1HANNUM C, CULPEPPER J, AMPBELL D, et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs [J]. Nature, 1994, 368(6472) : 643 -648.
  • 2BOHANNON J, CUI W, COX R, et al. Prophylactic treatment with fins-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection [J]. J Immunol, 2008, 180(5): 3038-3048.
  • 3LYMAN S D. Biologic effects and potential clinical applications of Flt3 ligand [J]. Curr Opin Hematol, 1998, 5 (3): 192 -196.
  • 4ALI S, CURTIN J F, ZIRGER J M, et al. Inflammatory and anti-glioma effects of an adenovirus expressing human soluble fins-like tyrosine kinase 3 ligand (hsFlt3L):treatment with hsFlt3L inhibits intracranial glioma progression [J]. Mol Ther, 2004, 10(6) : 1071 - 1084.
  • 5YO Y T, HSU K F, SHIEH G S, et al. Coexpression of Fh3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine [ J ]. Cancer Gene Ther, 2007, 14(11) : 904-917.
  • 6HOU S, KOU G, FAN X, et al. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU [J]. Cancer Immunol Immunother, 2007, 6(10) : 1605 - 1613.
  • 7KING G D, MUHAMMAD A K, CURTIN J F, et al. Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model [ J ]. Neuro Oncol, 2008, 10(1): 19-31.
  • 8YOON W S, CHOI W C, SIN J I, et al. Antitumor therapeutic effects of salmonella typhimurium containing Flt3 ligand expression plasmids in melanoma-bearing mouse [J]. Biotechnol Lett, 2007, 29(4) : 511 -516.
  • 9何贤辉,徐丽慧,刘毅,曾耀英.人β_2-微球蛋白基因克隆及其在大肠杆菌中的高效表达[J].生物工程学报,2004,20(1):99-103. 被引量:24
  • 10何贤辉,徐丽慧,刘毅,蔡小嫦,曾耀英.人PD-L1 cDNA的克隆及其胞外区蛋白在大肠杆菌中的表达[J].细胞与分子免疫学杂志,2004,20(6):659-663. 被引量:4

二级参考文献13

  • 1Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance[J]. Trends Immunol, 2001, 22(5): 265-268.
  • 2Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motifcarrying immunoreceptor[J]. Immunity, 1999, 11(2): 141-151.
  • 3Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice[J]. Science, 2001, 291(5502): 319-322.
  • 4Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J]. J Exp Med, 2000, 192(7): 1027-1034.
  • 5Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Ann Rev Immunol, 2002, 20: 29-53.
  • 6Gao W, Demirci G, Strom TB, et al. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival[J]. Transplantation, 2003, 76(6): 994-999.
  • 7Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med, 1999, 5(12): 1365-1369.
  • 8Iwai Y, Terawaki S, Ikegawa M, et al. PD-1 inhibits antiviral immunity at the effector phase in the liver[J]. J Exp Med, 2003, 198(1): 39-50.
  • 9Dubey C, Croft M, Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals[J]. J Immunol, 1996, 157(8): 3280-3289.
  • 10Eppihimer MJ, Gunn J, Freeman GJ, et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells[J]. Microcirculation, 2002, 9(2): 133-145.

共引文献26

同被引文献29

  • 1刘小林,段秀梅,方艳秋,谭岩,史宏博,车媛媛,刘力华.Flt3配体基因原核表达载体的构建、表达、纯化及生物学活性鉴定[J].吉林大学学报(医学版),2007,33(2):381-384. 被引量:2
  • 2Drexler HG,Quentmeier H FLT3:receptor and ligand.Growth Factors.2004; 22(2):71-73.
  • 3Kikushige Y,Yoshimoto G,Miyamoto T,et al.Human flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.J Immunol.2008;180(11):7358-7367.
  • 4Sitnicka E,Buza-Vidas N,Larsson S,et al.Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3:distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells.Blood.2003;102:881-886.
  • 5Ebihara Y,Wada M,Ueda T,et al.Reconstitution of human haematopoiesis in non-obese diabetic/severe combined immunodeficient mice by clonal cells expanded from single CD34+CD38-cells expressing Flk2/Flt3.Br J Haematol.2002; 119:525-534.
  • 6de Kruijf EJ,Hagoort H,Velders GA,et al.Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration.Haematologica.2010; 95(7):1061-1067.
  • 7Bertho JM,Prat M,Stefani J,et al.Correlation between plasma Flt3-ligand concentration and hematopoiesis during G-CSF-induced CD34+ cell mobilization.Stem Cells Dev.2008; 17(6):1221-1225.
  • 8Zhang Y,Guo C,Zhang H,et al.Synergistic protecting effect of cord blood CD34+ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated mice Int J Hematol.2009; 90(1):64-73.
  • 9Broxmeyer HE,Lu L,Cooper S,et al.Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.Exp Hematol.1995; 23(10):1121-1129.
  • 10Rusten LS,Lyman SD,Veiby OP,et al.The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.Blood.1996; 87(4):1317-1325.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部